# Mark V. DiBuono, MD – FDA Inspection, May 31, 2024

Source: https://www.keypedia.com/records/fda_inspections/mark-v-dibuono-md/1543d1bc-76a4-4eeb-86dd-8053c8c88d62
Source feed: FDA_Inspections

> FDA inspection 1239947 of Mark V. DiBuono, MD, May 31, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1239947
- Company Name: Mark V. DiBuono, MD
- Inspection Date: 2024-05-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1057149 - 2018-06-14
- FDA Inspection 875065 - 2014-04-21
- FDA Inspection 576565 - 2008-12-22

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/roberto-a-dookhan/01c2225f-a885-4421-9967-da323ce55cd8)

Company: https://www.keypedia.com/companies/mark-v-dibuono-md/d4a83632-9740-40b5-b692-f22b9766a077

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
